Children's Liver Disease Center, 302 Hospital
Beijing, China
Location status: Recruiting
Location contact
George Lau, MD
CONTACT
George Lau, MD, PhD
PRINCIPAL_INVESTIGATOR
Min Zhang, MD
CONTACT
NCT Number: NCT03190538
Nonalcoholic steatohepatitis (NASH) is now recognised as an increasing clinical problem in children. Steatosis without significant liver cell injury or fibrosis is the most common form of nonalcoholic fatty liver disease (NAFLD) in both adults and children. Studies in the adult population have variably suggested that steatosis is a benign nonprogressive condition and NASH is recognised as a potentially serious condition with significantly risk of morbidity and mortality.
A growing body of evidence suggests that children with NASH frequently show histopathological features that differ from those of adults. The prevalence of this pattern in a wide range of paediatric cases as well as other histopathological lesions and their relevance and prognostic significance in children with NAFLD remains to be determined. Thus the investigators would like to conduct a study of biopsies and clinical information to document the histological features of paediatric NAFLD, to explore the natural history of paediatric NAFLD, and to determine the frequency and prognostic value of these features.
Interested in participating?
Request Info1 year–18 year
All sexes
Observational
Beijing, China
Location status: Recruiting
George Lau, MD
CONTACT
George Lau, MD, PhD
PRINCIPAL_INVESTIGATOR
Min Zhang, MD
CONTACT
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
There will be no specific intervention to these paediatric NASH patient
Time frame: Through study completion, an average of 1 year
Whether the patients die from liver-related causes
Time frame: Through study completion, an average of 1 year
Whether the complication of cirrhosis i.e. ascites, hepatic encephalopathy, variceal bleeding occur during the follow-up
Time frame: Through study completion, an average of 2 year
Time frame: Through study completion, an average of 1 year
Whether the patients have liver transplant during the follow-up
Contact information is provided by the study sponsor or research team.
George Lau, MD, PhD
CONTACT
Yudong Wang, MD, PhD
CONTACT
Humanity and Health Research Centre
Other
Nonalcoholic Steatohepatitis in Chinese Children: a Long Term Follow-up
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07221188
Digestive System Diseases, Fatty Liver
Arcadia, California, United States
View Trial DetailsNCT03884075
Digestive System Diseases, Fatty Liver
Bethesda, Maryland, United States
View Trial DetailsNCT07403604
Body Weight, Diabetes Mellitus
New York, United States
View Trial DetailsNCT06138821
Body Weight, Body Weight Changes
Boston, Massachusetts, United States
View Trial Details